Submitted by paige-dawkins on Mon, 30/04/2018 - 15:54
Our CEO Clare Pelham, a member of the Sodium Valproate Expert Working Group, commented on the news of the new regulations surrounding sodium valproate.
Submitted by Nicola-Swanborough on Fri, 23/03/2018 - 14:10
Epilepsy Society's chief executive Clare Pelham has called today's announcement of new regulatory measures around sodium valproate, 'a landmark moment for all women who have ever been prescribed the epilepsy drug.'
Submitted by Nicola-Swanborough on Mon, 12/02/2018 - 17:03
New measures to avoid the exposure of unborn babies to the epilepsy drug, sodium valproate have been announced by the safety committee of the European Medicines Agency (EMA).
Submitted by Nicola-Swanborough on Tue, 06/02/2018 - 15:21
Epilepsy Society's chief executive Clare Pelham explains why mothers who have campaigned relentlessly about equality in women's health, are her inspiration as we celebrate #VotesforWomen
Submitted by carl-charlesworth on Wed, 27/09/2017 - 16:14
Watch and listen to Epilepsy Society's CEO Clare Pelham discussing sodium valproate on various BBC News programmes last week.
Submitted by Nicola-Swanborough on Fri, 18/08/2017 - 12:34
New survey launched to assess levels of awareness among women and girls of the potential risks around epilepsy drug, sodium valproate. The survey has been launched by Epilepsy Society, Epilepsy Action and Young Epilepsy.
Submitted by Nicola-Swanborough on Thu, 13/07/2017 - 11:02
Women and girls of childbearing age who are taking or have taken sodium valproate, are being invited to apply to take part in a public hearing about the epilepsy drug.
Submitted by Nicola-Swanborough on Fri, 10/02/2017 - 17:29
The Department of Health issues statement following BBC Radio 4's Today programme looking at impact if Britain withdraws from the European Medicines Agency (EMA).